These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33187811)

  • 1. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
    Wang Q; Berger NA; Xu R
    Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
    Wang Q; Berger NA; Xu R
    JAMA Oncol; 2021 Feb; 7(2):220-227. PubMed ID: 33300956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
    Wang QQ; Kaelber DC; Xu R; Volkow ND
    Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
    Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
    J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.
    Wang L; Kaelber DC; Xu R; Berger NA
    Blood Rev; 2022 Jul; 54():100931. PubMed ID: 35120771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
    García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
    J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
    Foxworthy B; Dai C; Davis EC; Xavier AC; Brackett J; Dickens D; Kahn A; Martinez I; Sharma A; Schwalm C; Foley J; Wilkes J; ; Bhatia S; Levine JM; Johnston EE; Wolfson JA
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31082. PubMed ID: 38804869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide analysis of adult hospitalizations with hematologic malignancies and systemic sclerosis.
    Romero Noboa ME; Litvin R; Sami F; Tanveer S
    ARP Rheumatol; 2023; 2(4):291-298. PubMed ID: 38174748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
    Wood WA; Neuberg DS; Thompson JC; Tallman MS; Sekeres MA; Sehn LH; Anderson KC; Goldberg AD; Pennell NA; Niemeyer CM; Tucker E; Hewitt K; Plovnick RM; Hicks LK
    Blood Adv; 2020 Dec; 4(23):5966-5975. PubMed ID: 33278301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
    Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care.
    Wang L; Wang W; Xu R; Berger NA
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101384. PubMed ID: 36494154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.
    Wang Q; Davis PB; Gurney ME; Xu R
    Alzheimers Dement; 2021 Aug; 17(8):1297-1306. PubMed ID: 33559975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.
    Oncologist; 2021 Feb; 26 Suppl 1(Suppl 1):S17-S18. PubMed ID: 33368829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review.
    Alehashemi S; Ward MM
    Mayo Clin Proc; 2023 Jan; 98(1):100-110. PubMed ID: 36470752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic Malignancies Are Associated with Adverse Perioperative Outcomes following Total Knee Arthroplasty.
    Newman JM; Wagner TC; Naziri Q; North WT; Navale SM; Klika AK; Barsoum WK; Higuera CA
    J Knee Surg; 2018 Apr; 31(4):291-301. PubMed ID: 28561155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
    Arcani R; Colle J; Cauchois R; Koubi M; Jarrot PA; Jean R; Boyer A; Lachamp J; Tichadou A; Couderc AL; Farnault L; Costello R; Venton G; Kaplanski G
    Ann Hematol; 2021 Nov; 100(11):2799-2803. PubMed ID: 34518918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
    Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
    Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.
    Song Q; Bates B; Shao YR; Hsu FC; Liu F; Madhira V; Mitra AK; Bergquist T; Kavuluru R; Li X; Sharafeldin N; Su J; Topaloglu U
    J Clin Oncol; 2022 May; 40(13):1414-1427. PubMed ID: 35286152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.